Search results for: Health Policy and Regulation
Filter search results
HIV and AIDS in the United Kingdom
1 January 1988
Since the first identification of the AIDS syndrome in Los Angeles in 1981 (and the description of the virus responsible- now termed HIV 1 -in 1983) health care professionals and…
Contact & engagement
…feedback and suggestions to help us improve future sessions. You can also sign up for our newsletter to get the latest updates and upcoming event details straight to your inbox….
Dr Tuba Saygın Avşar
26 January 2024
…health technology assessments, healthcare management, and health policy. She has co-led several major research projects funded by organizations like Innovate UK and NIHR, evaluating novel healthcare interventions and models. Tuba…
How Fair? Competition in the NHS
25 March 2010
…promoted competition for the provision of non-emergency hospital care to publicly-funded patients in England. In contrast to the health care competition introduced into the National Health Service under the Conservative…
OHE Consulting: Local and Global Expertise
14 September 2010
…and the Bill and Melinda Gates Foundation; government agencies in the UK and elsewhere; and individual companies and associations in the health care, pharmaceutical and life sciences industries. Inquiries are…
Transferability of HTA
4 January 2017
…make decisions about allocating their limited health care resources. In turn, HTA needs to be efficient and effective if investment in HTA is to be a sensible use of money….
The New Global Economics of Vaccines: Will the Scientific Potential Be Realised?
1 January 2007
…supplier. Research indicates that this has been the result of the interaction of supply and demand and, in particular, of the special characteristics of demand and supply in this industry….
Prevention pays off – so why aren’t we doing more of it?
5 June 2025
…and increasing the effectiveness of programme delivery by expanding vaccination options and integrating vaccinations into routine health check-ups. Most importantly, we need to pivot our thinking towards viewing health as…
New: Pay-for-Performance for Drugs and Incentives for Innovation
27 February 2012
…is highly controversial and is disliked by many health care providers, policy makers, and pharmaceutical companies. Interest is growing in schemes that involve “paying for pills by results”, that is,…